Here is a video about the world's first airway transplant using stem cell technique
http://www.guardian.co.uk/society/2008/nov/19/stem-cell-transplant-claudio-castilloHere my gap maker for this subjuct from Guardian.Doctors have successfully carried out the world's first airway transplant on a young woman using an organ partly grown from her own stem cells in a groundbreaking operation which scientists believe will
transform the future of surgery.
Surgeons replaced a
section of Claudia Castillo's windpipe, that had been irreparably damaged by tuberculosis, with a donated organ that was stripped of its cells and used as a scaffold for her stem cells.
Because Castillo's body recognises her own cells in the replacement organ she does not need to take powerful drugs to suppress her immune system, unlike all other transplant patients. The
technique raises the
prospect of transplants for patients whose organs are damaged by cancer, who then cannot take the drugs as they increase the risk of cancer returning.
'It is an organ her body will recognise' Professor Martin Birchall, from Bristol University, which carried out the stem cell engineering, said it would soon be possible to
create a
range of organs for transplants which patients' bodies will not reject. "In 20 years, this will be the most common form of surgery," he said.
A paper
published in the Lancet
medical journal online today, describes a cutting-edge collaboration
involving doctors in three countries: Spain, the UK and Italy. In the paper, the
authors write: "We think this represents a milestone and hope it will unlock the door for a safe and recipient-tailored transplantation of the airway in
adults and children. We hope that these future patients will no longer suffer the trauma of speech loss, severe shortness of breath and limited social activities."
Castillo, 30, was referred to the Hospital Clinic, University of Barcelona, because TB had damaged her airways. The upper part of her windpipe was surgically repaired, but it was not possible to undo damage to the tube connecting the main windpipe to the left lung. Doctors rarely recommend a windpipe transplant because condemning a patient to a lifetime of immunosuppressant drugs - which makes them vulnerable to infections - is only thought worthwhile if it is the only way to save their life.
The standard
option for somebody like Castillo would have been
removal of the left lung, which would have
restored her health but probably shortened her life.
Based on work done on animals, Professor Paolo Macchiarini offered her a
procedure untried on humans. "We proposed tissue engineering to this lady," he said.
A piece of windpipe was taken from a donor and treated to
remove all cellular material that Castillo's body might
reject. Stem cells were
removed from her hip and cultivated by
researchers from Bristol University until they were ready to develop into cartilage, which would grow around the outside of the trachea.
More cells were taken from the mucous membrane around the tube
linking her main windpipe to her right lung. These cells were treated by another Bristol team to be seeded on the inside of the new
section of windpipe. Then scientists at Milan university
constructed a bioreactor to foster the growth of the mucous membrane cells and the cartilage.
The operation took place on June 12. Macchiarini said: "As I was operating, I asked myself am I doing the right thing. I was very much afraid."
If things had gone wrong, Castillo knew her lung would have to be
removed. But five months on, she is well and there is no sign of
rejection of the transplant.
A tailor-made effort
involving top scientists in three countries is an expensive exercise, but the scientists are confident that costs will come down and that the
technique will help thousands of people in years to come. Professor Anthony Hollander, from Bristol, said: "The trick is to develop ways of scaling up," he said.
But the Barcelona hospital, said Macchiarini, had already made savings by no longer having to admit Castillo to
intensive care twice a week at a cost of £3,000 a day, as it has done for the last three years.
Birchall said about 270 UK patients could
benefit from a tissue-engineered windpipe transplant operation. But he believes it will
eventually be possible to use the
technique for all kinds of transplants